The tumour-localised expression of an anti-EGFR BiTE by an oncolytic adenovirus synergised with anti-FR-α CAR T cells in a mouse model of pancreatic cancer, with the enhanced accumulation of T cells at tumour sites and an increase in proliferation and activation markers expressed on the infiltrating lymphocytes [113]. Here, EGFR is linked to neoplasm.